Rigel Announces Second Quarter 2019 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Fiserv president resigns, interim leaders named for financial unit
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Rigel Pharma (RIGL) Tops Q2 EPS by 2c, Revenues Beat
August 6, 2019 5:40 PM EDTRigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $10.46 million versus the consensus estimate of $9.28 million.
"Execution is the key to Rigel's success, and has enabled us to increase... More
